Alnylam Pharmaceuticals, Inc. (ALNY)
227.66
+3.63
(+1.62%)
USD |
NASDAQ |
Oct 26, 16:00
227.60
-0.06
(-0.03%)
After-Hours: 20:00
Alnylam Pharmaceuticals Price : 227.66 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 226.24 | 232.48 | 224.10 | 227.66 | 1.437M |
| Oct 23, 2026 | 227.28 | 229.39 | 222.00 | 224.03 | 1.056M |
| Oct 22, 2026 | 224.92 | 229.82 | 223.76 | 227.28 | 2.212M |
| Oct 21, 2026 | 227.86 | 230.84 | 224.88 | 225.10 | 1.181M |
| Oct 20, 2026 | 237.73 | 238.96 | 229.54 | 230.71 | 1.505M |
| Oct 19, 2026 | 232.64 | 236.54 | 231.26 | 233.29 | 1.344M |
| Oct 16, 2026 | 235.18 | 237.98 | 231.29 | 231.83 | 1.405M |
| Oct 15, 2026 | 230.00 | 234.30 | 228.12 | 234.03 | 1.257M |
| Oct 14, 2026 | 224.49 | 229.56 | 222.25 | 224.47 | 1.106M |
| Oct 13, 2026 | 228.93 | 229.52 | 221.56 | 223.82 | 1.119M |
| Oct 12, 2026 | 233.13 | 233.60 | 226.35 | 227.02 | 916918.0 |
| Oct 09, 2026 | 224.74 | 232.94 | 222.70 | 232.68 | 959451.0 |
| Oct 08, 2026 | 222.03 | 225.90 | 218.39 | 224.53 | 1.772M |
| Oct 07, 2026 | 224.39 | 230.42 | 222.46 | 224.41 | 1.064M |
| Oct 06, 2026 | 221.02 | 229.18 | 217.18 | 223.94 | 1.356M |
| Oct 05, 2026 | 218.36 | 222.08 | 215.46 | 219.89 | 1.281M |
| Oct 02, 2026 | 231.31 | 231.36 | 219.40 | 219.72 | 1.662M |
| Oct 01, 2026 | 248.21 | 251.71 | 230.06 | 231.18 | 2.017M |
| Sep 30, 2026 | 253.68 | 254.44 | 246.66 | 246.74 | 1.044M |
| Sep 29, 2026 | 254.86 | 257.27 | 251.02 | 254.07 | 787081.0 |
| Sep 28, 2026 | 256.28 | 256.60 | 248.12 | 255.36 | 1.148M |
| Sep 25, 2026 | 248.39 | 256.66 | 247.51 | 255.96 | 1.085M |
| Sep 24, 2026 | 246.51 | 251.81 | 245.52 | 249.59 | 933738.0 |
| Sep 23, 2026 | 249.99 | 253.81 | 245.34 | 246.51 | 1.482M |
| Sep 22, 2026 | 246.86 | 255.51 | 244.13 | 251.65 | 1.132M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 43.42 |
| Vertex Pharmaceuticals, Inc. | 517.49 |
| BridgeBio Pharma, Inc. | 68.15 |
| Pfizer Inc. | 29.79 |
| Regeneron Pharmaceuticals, Inc. | 807.67 |
Price Related Metrics
| PE Ratio | 38.44 |
| PS Ratio | 6.517 |
| Price to Book Value | 22.48 |
| Price to Free Cash Flow | 39.44 |
| Earnings Yield | 2.60% |
| Market Cap | 30.45B |
| Operating PE Ratio | 31.32 |
| Normalized PE Ratio | 39.55 |